Company Profiles

driven by the PitchBook Platform

Gelesis

Description

Operator of a clinical stage biotechnology company. The company focuses on the development of novel therapies to induce weight loss and improve glycemic control in overweight and obese patients, including those with prediabetes and diabetes.

2006

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$31.5M

Latest Deal Amount

$95.5M

Total Amount Raised

Description

Operator of a clinical stage biotechnology company. The company focuses on the development of novel therapies to induce weight loss and improve glycemic control in overweight and obese patients, including those with prediabetes and diabetes.

Website:

www.gelesis.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

500 Boylston Street Suite 1600 Boston, MA 02116United States +1 (617) 456-4718
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Gelesis's full profile, request a free trial.

Gelesis Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Gelesis Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Gelesis Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cape Family FundOtherMinority000 0000000 0000
Cormorant Asset ManagementHedge FundMinority000 0000000 0000
Exotech Bio SolutionsCorporationMinority000 0000000 0000
Hercules CapitalGrowth/ExpansionMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Cape Family Fund Other
Cormorant Asset Management Hedge Fund
Exotech Bio Solutions Corporation
Hercules Capital Growth/Expansion
Individual Investor Angel (individual)

Gelesis Executive Team (10)

NameTitleBoard
Seat
Contact
Info
David PassChief Operating Officer
Eyal Ron Ph.DChief Technology Officer
Elliot MaltzController
Alessandro Sannino Ph.DChief Project Scientist
Yishai ZoharChief Executive Officer, Board Member and Co-Founder
David Pass Chief Operating Officer
Eyal Ron Ph.D Chief Technology Officer
Elliot Maltz Controller
Alessandro Sannino Ph.D Chief Project Scientist
Yishai Zohar Chief Executive Officer, Board Member and Co-Founder

Gelesis Board Members (8)

NameRepresentingRoleSinceContact
Info
Elon BomsSelfBoard Member000 0000
John LaMattina Ph.DPureTech VenturesChairman000 0000
Meghan FitzGeraldSelfBoard Member000 0000
Mendy AxleradGelesisDirector, Board Member and Co-Founder000 0000
Raju Kucherlapati Ph.DSelfBoard Member000 0000
Elon Boms Board Member Self
John LaMattina Ph.D Chairman PureTech Ventures
Meghan FitzGerald Board Member Self
Mendy Axlerad Director, Board Member and Co-Founder Gelesis
Raju Kucherlapati Ph.D Board Member Self
Request full access to PitchBook